Abstract:Background: Esophageal adenocarcinoma (EAC) develops in pre-cancer columno-glandular hyperplasia, intestinal metaplasia and dysplasia that replaces squamous epithelium and characterizes Barrett's esophagus (BE). We reported CDKN2A/p16 deletions in up to 69% of BE patients who progressed to dysplasia and EAC, suggesting that p16 loss may drive progression of BE to EAC. LGR5+ cardia like stem cells in the squamocolumnar junction (SCJ) of mouse stomach have been implicated in the cellular origins of BE, and glandular hyperplasia/metaplasia (MGHP) and dysplasia and enhanced inflammation in SCJ were reported in interleukin 1 beta (IL1b) transgenic mice. Our hypothesis is that p16 deletion in LGR5+ cells that give rise to glandular epithelium in SCJ of IL1b mice may accelerate glandular hyperplasia and metaplasia and augment progression to dysplasia and EAC. Design: We tested the hypothesis using conditional knockout of CDKN2A/p16 in IL1b mouse targeting SCJ LGR5+ cells. Model A genotype is p16del: (Lgr5-CreERT2 +/-; IL1b wt/tg; p16 fl/fl) and control model C is p16 wild type (wt): (Lgr5-CreERT2 +/-; IL1b wt/tg; p16 wt/wt). Conditional knockout was induced with intraperitoneal tamoxifen injection. All mice were given bile acid in drinking water, daily. Mice were euthanized and gross and histologic alterations in SCJ, stomach, small intestine (SI) and colon were assessed over time, until 16 months. MGHP was scored as the number of glandular profiles in each section of SCJ, and inflammation and dysplasia were evaluated and scored (0 to 3) in H&E-stained sections. Results: We examined 39 mice: 19 model A (p16del) and 20 model C (p16wt). Mice were grouped into 3 groups from 3 to 16 months. The SCJ of p16del mice exhibited larger areas of hyperplastic cardia-type mucous glands compared to p16wt mice, showing higher numbers of gland profiles (median 17 vs. 8 gland profiles, P=9-5). Higher inflammation scores were also seen in p16del mice ages 3-7 and 7-12 months (P=.036 and P=.013). P16del mice showed higher dysplasia scores overall (P=.013), particularly in mice ages 7-16 months (P=.038). There was a positive correlation between MGHP and inflammation (P=.004) and between inflammation and dysplasia (P=.021). No significant alterations were seen in the stomach, SI, or colon of p16del vs p16wt mice. Conclusions: Loss of p16 alone is not sufficient to develop neoplastic alterations in stomach, SI and colon. Deletion of p16 in LGR5+ cardia-like stem cells in the squamocolumnar junction of mouse stomach, together with IL1b and BA-induced inflammation and cellular injury, is associated with increased MGHP, inflammation, and dysplasia. The model implicates p16 in the early stages of esophageal carcinogenesis, similar to human disease, providing a model to further dissect the contributing molecular mechanisms of progression to esophageal dysplasia and cancer. Citation Format: Jing Sun, Elena V. Komissarova, Caitlin Hills, Tyler Seckar, Gloria H. Su, Jorge Sepulveda, Timothy L. Wang, Antonia R. Sepulveda. CDKN2A/p16 knockout in LGR5+ progenitor cells augments mucous gland hyperplasia/metaplasia, inflammation, and dysplasia in mouse stomach squamocolumnar junction [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 929.

The Establishment of Esophageal Precancerous Lesion Model by Using p53 Conditional Knockout Mouse in Esophageal Epithelium

Involvement of P53 Mutation and Mismatch Repair Proteins Dysregulation in NNK-Induced Malignant Transformation of Human Bronchial Epithelial Cells

DNA polymerase β deficiency promotes the occurrence of esophageal precancerous lesions in mice

A Novel Mouse Model for Colitis-Associated Colon Carcinogenesis Induced by 1,2-Dimethylhydrazine and Dextran Sulfate Sodium

Modeling the Etiology of p53-mutated Cancer Cells

Mechanism of N-Methyl-N-Nitroso-Urea-Induced Gastric Precancerous Lesions in Mice

Single-Cell Analysis of Different Stages of Oral Cancer Carcinogenesis in a Mouse Model

p53 mutation biases squamocolumnar junction progenitor cells towards dysplasia rather than metaplasia in Barrett's oesophagus

Mouse models to investigate in situ cell fate decisions induced by p53

Establishment and Characterization of Esophageal Squamous Cell Carcinoma Patient-Derived Xenograft Mouse Models for Preclinical Drug Discovery

The clinical significance of p53 and pRb signal pathway in esophageal cancer patients

P53 Mutation Biases Squamocolumnar Junction Progenitor Cells Towards Dysplasia Rather Than Metaplasia in Barrett’s Oesophagus

Abstract 929: CDKN2A/p16 knockout in LGR5+ progenitor cells augments mucous gland hyperplasia/metaplasia, inflammation, and dysplasia in mouse stomach squamocolumnar junction

Conditional Knockout Mouse Models of Cancer

Generation and multiomic profiling of a TP53/CDKN2A double-knockout gastroesophageal junction organoid model

Conditional knockout mouse model reveals a critical role of peroxiredoxin 1 in oral leukoplakia carcinogenesis

Hippo Cooperates with P53 to Maintain Foregut Homeostasis and Suppress the Malignant Transformation of Foregut Basal Progenitor Cells.

Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth

Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

Establishment of a DEN-induced mouse model of esophageal squamous cell carcinoma metastasis

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene